Daxor

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Daxor and other ETFs, options, and stocks.

About DXR

Daxor Corp. is a biotechnology company which develops and manufactures the BVA-100 blood volume analyzer, an instrument that measures human blood volume. Its IDANT division provides autologous blood storage and andrology services, such as semen analysis, sperm washing, and general lab testing. 

CEO
Michael R. Feldschuh
CEOMichael R. Feldschuh
Employees
Employees
Headquarters
Oak Ridge, Tennessee
HeadquartersOak Ridge, Tennessee
Founded
1970
Founded1970
Employees
Employees

DXR Key Statistics

Market cap
66.72M
Market cap66.72M
Price-Earnings ratio
6.33
Price-Earnings ratio6.33
Dividend yield
Dividend yield
Average volume
18.53K
Average volume18.53K
High today
$11.68
High today$11.68
Low today
$11.36
Low today$11.36
Open price
$11.36
Open price$11.36
Volume
799.00
Volume799.00
52 Week high
$14.76
52 Week high$14.76
52 Week low
$7.10
52 Week low$7.10

Stock Snapshot

The current Daxor(DXR) stock price is $11.45, with a market capitalization of 66.72M. The stock trades at a price-to-earnings (P/E) ratio of 6.33.

On 2026-03-05, Daxor(DXR) stock moved within a range of $11.36 to $11.68. With shares now at $11.45, the stock is trading +0.8% above its intraday low and -1.9% below the session's peak.

Trading volume for Daxor(DXR) stock has reached 799, versus its average volume of 18.53K.

Over the past 52 weeks, Daxor(DXR) stock has traded between a high of $14.76 and a low of $7.10.

Over the past 52 weeks, Daxor(DXR) stock has traded between a high of $14.76 and a low of $7.10.

DXR News

TipRanks 2d
Daxor issues update in Letter to Shareholders

Daxor (DXR) issued a corporate update in a Letter to Shareholders filed in its certified shareholder report on Form N-CSR on March 2, 2026 from CEO & President,...

TipRanks 2d
Daxor reports NAV per share of $9.07

The company said, “The most significant corporate highlight of the year was the receipt of FDA 510(k) clearance in August 2025 for Daxor’s (DXR) next-generation...

People also own

Based on the portfolios of people who own DXR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.